Scarsini, Roberto
,
Shanmuganathan, Mayooran
Kotronias, Rafail A.
Terentes-Printzios, Dimitrios
Borlotti, Alessandra
Langrish, Jeremy P.
Lucking, Andrew J.
Ribichini, Flavio
Ferreira, Vanessa M.
Channon, Keith M.
Garcia-Garcia, Hector M.
Banning, Adrian P.
De Maria, Giovanni Luigi http://orcid.org/0000-0003-3572-1855
Funding for this research was provided by:
British Heart Foundation (CH/16/1/32013)
BHF Centre of Research Excellence, Oxford (RG/13/1/30181)
Article History
Received: 3 March 2021
Accepted: 23 April 2021
First Online: 5 May 2021
Declarations
:
: Dr RS is on the scientific advisory board for Abbott Laboratories. Dr GLDM has received grants for Abbott Laboratories and Miracor Medical SA. AB reports institutional funding for fellowship from Boston Scientific and speaker fees from Boston Scientific, Miracor Medical SA, Medtronic and Abbott. All other authors report no conflict.
: All patients provided informed consent for participation in the OxAMI study.
: All patients provided informed consent for anonymous publication of the results of the study.
: OxAMI study was approved by the Oxford University Hospitals ethics committee and conducted in accordance with the Declaration of Helsinki (REC number 10/H0408/24).